Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: X4 Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Dianthus Therapeutics Inc. May 23, 202496.5%
-
Spyre Therapeutics Inc. June 6, 202369.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2024 | X4 Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
| Jun 13, 2023 | X4 Pharmaceuticals Inc. | Grant or award | +45,000 | — | — |
Questions about Alison Frances Lawton
What boards is Alison Frances Lawton on?
Alison Frances Lawton sits on the boards of Dianthus Therapeutics Inc., ProQR Therapeutics N.V., Spyre Therapeutics Inc. and X4 Pharmaceuticals Inc.
How long has Alison Frances Lawton served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.